Navigation Links
Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
Date:2/8/2011

purchase nor a solicitation of an offer to sell shares of Crucell, nor shall there be any sale or purchase of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  The Offer is being made pursuant to the tender offer statement on Schedule TO (including the Offer Document, a related ADS letter of transmittal and tender and proxy form, and other relevant materials) filed by the Offeror with the U.S. Securities and Exchange Commission (SEC) on 8 December 2010.

SHAREHOLDERS OF CRUCELL ARE URGED TO READ THESE AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE OFFER.  Copies of Johnson & Johnson's filings with the SEC may be obtained at the SEC's web site (www.sec.gov) or by directing a request to Johnson & Johnson at Johnson & Johnson, One Johnson & Johnson Plaza, New Brunswick, NJ 08933, U.S.A. (Attention: Corporate Secretary's Office).  The Offer Document is available free of charge on the website of Crucell at www.crucell.com. Hard copies of the Offer Document will also be available at the offices of Crucell at Archimedesweg 4-6, 2333 CN Leiden, the Netherlands; at the offices of the Dutch Settlement Agent, ING Bank N.V., Bijlmerdreef 888 1102 MG Amsterdam, the Netherlands (Attention: Sjoukje Hollander/Remko Los), telephone: + 31 20 563 6546 / + 31 20 563 6619, email: iss.pas@ing.nl); and at the offices of the U.S. Settlement Agent, Computershare Trust Company, N.A., 250 Royall Street, Canton, MA 02021.

About CrucellCrucell N.V. (NYSE Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) is a global biopharmaceutical company focused on research dev
'/>"/>

SOURCE Johnson & Johnson; Crucell
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
2. ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell
3. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
4. Amarin Provides 2010 Year-End Review to Shareholders
5. BD Announces Webcast of Annual Meeting of Shareholders
6. Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals
7. Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010
8. China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
9. Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock
10. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
11. Valeant and Biovail Announce Results of Special Meetings of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... manufactures and markets innovative proprietary products to treat voiding ... 27th Annual ROTH Conference on Tuesday, March 10, 2015. ... Brett Reynolds , Chief Financial Officer, will present at ... on one at the conference at the Ritz Carlton ...
(Date:2/26/2015)... 27, 2015 RnRMarketResearch.com adds ... research report to its store. This report p ... pipeline. The report "Corneal Ulcers - Pipeline Review, ... development for Corneal Ulcers. Corneal Ulcers are primarily ... infections, viral infections & fungal infections. The symptoms ...
(Date:2/26/2015)... Ind. , Feb. 26, 2015  Mobility Ventures ... an agreement with Bank of America (NYSE: ... nationwide to receive financing of the revolutionary MV-1 - ... designed from the ground up to provide safe and ... applicants can use their loan to purchase a new ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Sermo ( http://www.sermo.com/client ), the ... free Sermo Report titled, " FDA Committee Recommends Approval ... the introduction of an investigational oral antiplatelet treatment for ... of physicians feel that ticagrelor will likely affect the ...
... Inc. (OTC Bulletin Board: AEMD ), the ... disease and cancer, announced today that the Medanta Independent ... has approved a treatment program entitled: "Use of the ... with Standard of Care (SOC) Drug Therapy."  The Medicity ...
Cached Medicine Technology:Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients 2Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 2Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 3Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 4Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 5Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 6
(Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
(Date:2/28/2015)... February 28, 2015 Gerald “Solutionman” Haman ... blocks or barriers to innovative thinking. “The #1 ... was lack of tools,” reports Haman, who created the ... 57% of people felt that they did not have ... tools and resources to stimulate innovation. , Solutionman’s monthly ...
(Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation ... time limits. They stated that in many cases, missing an ... nullify it. Many a time, delays in making an injury ... BC law. As a result, experts at Jiwa Law Corporation ... a personal injury lawyer in order to know more about ...
(Date:2/28/2015)... February 28, 2015 For those people ... person, the Mesothelioma Applied Research Foundation (Meso ... Tuesday, March 3, starting at 9:30 AM. , The ... registration. The broadcast can be accessed through any browser ... . , The Symposium is a unique event that ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
... cancer, the side effects of chemotherapy and other ... research based on nano- and microtechnology from Tel ... as more effective cancer treatment. , New drug ... Tel Aviv University,s Department of Biochemistry allows drugs ...
... Feb. 19 A new analysis from the JUPITER ... in San Diego, California describes details of the stroke ... This data adds to the primary analysis of ... 20mg significantly reduced the risk of stroke by nearly ...
... Cholesterol-lowering statins, used by millions of Americans to ... problems, according to researchers at Texas Health Presbyterian ... and the influence of statin drugs," appears in ... physicians make quicker, more accurate diagnoses of suspected ...
... address the unmet and undiagnosed health needs of students ... communities , Alliance College -Ready Public School,s College-Ready ... Street, Los Angeles, 90015 will host a free school ... 11:00 a.m. to 3:00 p.m. Students and families attending ...
... marketing promotional products company, offers a specialty store filled with ... ... Lewiston, ME (PRWEB) February 19, 2009 -- Crestline Custom ... that trades on its easy, customer-friendly ordering process, offers scores ...
... Mardil Inc., a cardiac medical device company with ... the appointment of Daniel A. Pelak to its board ... of cardiac medical devices will serve as a guiding ... its unique device from the development stage to human ...
Cached Medicine News:Health News:New 'bubble' targets only cancer cells 2Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 2Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 3Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 4Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:High Achieving Los Angeles Charter School to Hold Health Fair Offering Free Medical Screening, Treatment and Information to Students and Their Families 2Health News:Crestline is the Source for Great Green Giveaways 2Health News:Crestline is the Source for Great Green Giveaways 3Health News:Mardil Inc. Appoints Medical Device Veteran Daniel A. Pelak to Its Board of Directors 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: